PHarmaceutical tech@2x
  • News

    Most Read

    • Study finds Pfizer, BioNTech’s vaccine could prevent UK variant Covid-19
    • Gritstone, NIAID enter clinical trial agreement for next-gen Covid-19 vaccine
    • Lilly and Merus partner to develop T-Cell re-directing antibody therapies

    Most Recent

    Infectious Diseases

    Study finds Pfizer, BioNTech’s vaccine could prevent UK variant Covid-19

    21 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Pandemic has been catastrophic for women in Canada – leading macroeconomic influencers
    • Canada looks to enhance its talent pool post Covid – leading macroeconomic influencers
    • Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership

    Most Recent

    Pandemic has been catastrophic for women in Canada – leading macroeconomic influencers

    21 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
      • Respiratory

    Most Read

    • International update: Global Covid deaths reach new daily high – vaccines may need re-design to cope with new variants
    • Coronavirus company news summary – Pfizer/BioNTech Covid-19 vaccine found to be effective against UK variant – GC Pharma moves closer to submitting a EUA in Korea for its plasma Covid-19 therapy
    • Study finds Pfizer, BioNTech’s vaccine could prevent UK variant Covid-19

    Most Recent

    International update: Global Covid deaths reach new daily high – vaccines may need re-design to cope with new variants

    21 Jan 2021
  • Themes
  • Deals

    Most Read

    • Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership
    • Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m
    • NewAmsterdam Pharma raises $196m through Series A funding round

    Most Recent

    Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership

    19 Jan 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • TOTE® SYSTEMS
    • RSD
    • Kiskun Meridian

    Most Recent

    Manufacturing

    TOTE® SYSTEMS

    20 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • US Election
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Tackling Covid-19 variants with next-generation vaccines

Tackling Covid-19 variants with next-generation vaccines

Three new, highly transmissible variants of Covid-19 have been front and centre of the news...

21 January 2021
Tonix Pharmaceuticals strikes licensing deal to expand use of intranasal drug for metabolic disorders

Tonix Pharmaceuticals strikes licensing deal to expand use of intranasal drug for metabolic disorders

20 January 2021
Impact of the US election result on the Affordable Care Act and Medicare

Impact of the US election result on the Affordable Care Act and Medicare

19 January 2021
Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership

Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership

Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against...

19 January 2021
FDA accepts regulatory submission for Pfizer and OPKO Biologic’s long-acting growth hormone Somatrogon

FDA accepts regulatory submission for Pfizer and OPKO Biologic’s long-acting growth hormone Somatrogon

19 January 2021
Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m

Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m

Thermo Fisher Scientific has acquired Novasep's viral vector manufacturing business in Belgium, Henogen, for about...

18 January 2021
The UK Records the highest-ever number of Covid-19 cases, despite national lockdown and vaccine

The UK Records the highest-ever number of Covid-19 cases, despite national lockdown and vaccine

18 January 2021
Forxiga’s priority review and breakthrough designation highlight potential to differentiate in CKD space

Forxiga’s priority review and breakthrough designation highlight potential to differentiate in CKD space

18 January 2021
Enter Amazon Pharmacy: the beginning of a great online pharmacy fight?

Enter Amazon Pharmacy: the beginning of a great online pharmacy fight?

Two years after its acquisition of PillPack, Amazon has further expanded its presence in the...

18 January 2021
A standard approach to drug development for accessing the globe

A standard approach to drug development for accessing the globe

15 January 2021

Latest News

Drug Development

Adamis submits IND application to FDA for Covid-19 treatment

21 Jan 2021
Infectious Diseases

Study finds Pfizer, BioNTech’s vaccine could prevent UK variant Covid-19

21 Jan 2021
Clinical Trials

Gritstone, NIAID enter clinical trial agreement for next-gen Covid-19 vaccine

20 Jan 2021
Oncology

Lilly and Merus partner to develop T-Cell re-directing antibody therapies

20 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more